Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic.
J Law Med Ethics
; 50(S1): 8-23, 2022.
Article
em En
| MEDLINE
| ID: mdl-35902089
ABSTRACT
The U.S. has the tools to end the HIV epidemic, but progress has stagnated. A major gap in U.S. efforts to address HIV is the under-utilization of medications that can virtually eliminate acquisition of the virus, known as pre-exposure prophylaxis (PrEP). This document proposes a financing and delivery system to unlock broad access to PrEP for those most vulnerable to HIV acquisition and bring an end to the HIV epidemic.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Infecções por HIV
/
Epidemias
/
Profilaxia Pré-Exposição
Tipo de estudo:
Health_economic_evaluation
Limite:
Humans
Idioma:
En
Revista:
J Law Med Ethics
Assunto da revista:
ENFERMAGEM
/
ETICA
/
JURISPRUDENCIA
/
MEDICINA
/
PESQUISA EM SERVICOS DE SAUDE
Ano de publicação:
2022
Tipo de documento:
Article